A Study of AK109 Combined With AK104 in Patients With Advanced Solid Tumors

Clinical trial NCT05142423 · RECRUITING

Trial details

NCT number: NCT05142423
Sponsor: Akeso
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2021-11-03
Primary completion: 2027-04-01
Enrollment: 198

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.